• SENSEX 74,315.61
    1,533.72 (+2.11%)
  • BANKNIFTY 55,810.50
    494.50 (+0.89%)
  • Reliance Industries
    1,223.30 1,611.20(%)
  • NSE
    1,777.00 1,878.00(%)
  • TCS
    2,386.70 3,336.70(%)
  • HCL Technologies
    1,376.00 1,770.00(%)
  • HDFC Bank
    728.55 1,020.35(%)
  • Infosys
    1,126.40 1,727.85(%)
  • Indian Hotels Co
    752.50 757.10(%)
  • Gallantt Ispat L
    648.45 946.70(%)
  • ICICI Bank
    1,395.00 1,479.90(%)
  • NMDC
    70.56 70.15(%)
  • Billionbrains
    200.85 227.00(%)
  • Axis Bank
    1,294.40 1,418.30(%)
  • Netweb Technol.
    4,666.00 2,942.45(%)
  • Bajaj Finance
    975.00 1,177.60(%)
  • HDB FINANC SER
    536.65 536.65(%)
  • Bharti Airtel
    1,871.20 2,174.70(%)
  • SS Retail
    741.55 603.00(%)
  • Eternal
    324.35 368.40(%)
  • Kotak Mah. Bank
    448.85 452.98(%)
  • MV Electrosystems
    918.00 510.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Ind-Swift Laboratories Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 7927.0
  • ISIN : INE915B01019
357.95 -12 (-3.18%)
  • As on 15 Oct 2026 (EOD)

  • Today’s Low

    355.00

  • Today’s High

    377.20

  • Open

    366.90

  • Perv Close

    369.70

  • 52W Low

    87.15

  • 52W High

    424.75

Key Indicators

  • P/E(TTM)

    46.68

  • Mar.Cap (₹Cr.)

    3,112.79

  • Div & Yield %

    0.00

  • Book Value(₹)

    157.53

  • Debt-Equity Ratio

    -3.18

  • AGM Date

    15-Oct-2026

  • EPS

    7.68

  • P/E Ratio

    46.68

Financials Ratios

  • Debt-Equity Ratio

    0.61

  • Mar.Cap (₹Cr.)

    3,112.79

  • RONW (%)

    19.32

  • ROCE (%)

    20.71

Score Board

  • Equity (₹ in Cr.)

    86.96

  • BV (₹)

    157.50

  • Sales( ₹ in Cr.)

    635.89

  • NP (in Cr.)

    50.83

  • NP Var(%)

    1837.0

  • Div%

    0.0

  • CPS (₹)

    9.40

  • EPS (₹)

    5.80

  • Traded Value (₹ in Lakhs)

    3,117.57

  • 52 Week High

    424.75

  • 52 Week Low

    87.15

  • Price BSE

    359.0

  • Price NSE

    358.00

  • Market Capital( in Cr.)

    3,117.57

  • P/C Ratio

    38.40

  • P/E Ratio

    61.40

  • Price Vs.BV

    5.80

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 635.89 562.17 1,672.57 1,151.96 988.09 856.58
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 635.89 562.17 1,672.57 1,151.96 988.09 856.58
Other Income 46.96 291.95 479.29 33.28 42.50 23.13
Stock Adjustments 28.91 10.36 -66.92 12.34 39.47 2.48
Total Income 711.76 864.48 2,084.94 1,197.58 1,070.06 882.19
EXPENDITURE :            
Raw Materials 312.40 295.36 782.01 629.18 537.62 427.47
Power and Fuel Cost 16.42 13.72 73.61 76.07 58.40 37.31
Employee Cost 136.33 115.33 233.43 132.70 124.62 104.17
Other Manufacturing Expenses 42.85 37.50 57.15 38.53 36.51 28.76
Selling and Administration Expenses 102.24 97.07 122.77 63.98 62.17 78.98
Miscellaneous Expenses 19.33 13.97 37.86 28.40 16.22 1.87
Employee Benefit Expenses 136.33 115.33 233.43 132.70 124.62 104.17
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 629.56 572.94 1,306.83 968.85 835.54 678.56
Operating Profit 82.18 291.54 778.11 228.73 234.52 203.63
Interest 1.40 2.92 103.77 92.17 95.55 100.22
Gross Profit 80.78 288.62 674.34 136.56 138.97 103.41
Depreciation 30.57 24.48 80.41 57.36 130.97 87.29
Profit Before Tax 50.21 264.14 593.93 79.20 8.00 16.12
Current Tax 13.06 11.88 68.60 13.36 24.62 11.04
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -5.40 -3.83 -10.84 23.36 -10.92 9.48
Reported Net Profit 42.56 256.09 536.18 42.47 -5.71 -4.40
Extraordinary Items -8.27 259.01 389.96 -13.39 -3.13 0.00
Adjusted Net Profit 50.83 -2.92 146.22 55.86 -2.58 -4.40
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward -142.89 -398.98 -935.16 -80.16 -74.45 -70.05
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -100.34 -142.89 -398.98 -37.69 -80.16 -74.45
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 4.90 37.25 79.77 7.10 -0.95 -0.74
Earnings Per Share(Adj)-Unit Curr 4.90 37.25 79.77 7.10 -0.95 -0.74
Book Value 157.74 158.56 118.75 82.26 72.91 71.55
Book Value(Adj)-Unit Curr 157.74 158.56 118.75 82.26 72.91 71.55

Shareholding Pattern

  • Promoter Group

    42.93%

  • Public Share Holding

    57.07%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 32,882,521 37.81 32,882,521 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 4,451,757 5.12 4,451,757 19
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 37,334,278 42.93 37,334,278 20
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 76 0.00 76 2
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 9,479,170 10.90 9,479,170 14
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 300 0.00 300 1
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 134,000 0.15 134,000 2
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 9,613,546 11.05 9,613,546 19
2] Non Institution
Bodies Corporate 5,465,186 6.28 5,455,386 254
Clearing Members 93,225 0.11 93,225 27
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 2,015,605 2.32 2,015,605 570
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 943,157 1.08 943,157 949
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 18,965,301 21.81 18,965,301 140
Individuals holding nominal share capital up to Rs. 1 lakh 11,648,055 13.39 11,527,707 40,101
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 712,770 0.82 712,770 4
Sub Total 40,013,734 46.01 39,883,586 42,073
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 86,961,558 100.00 86,831,410 42,112

Company Background

Ind-Swift Laboratories LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Ind-Swift Laboratories Ltd
  • BSE Code : 7927.0
  • ISIN : INE915B01019

  • Incorporation Year

    1995

  • Registered Office

    SCO 850 Shivalik Enclave
    NAC Manimajra, Chandigarh,
    Chandigarh-160101

  • Telephone

    91-0172-5061850/2730920

  • FAX

    91-0172-2730504/2736294

  • Chairman

    N R Munjal

  • Managing Director

  • Company Secretary

    Pradeep Verma

  • Auditor

    Rattan Kaur & Associates

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    Alankit Assignments Ltd
    205/208,
    Anarkali Market,Jhandewalan Extn
    Mumbai - New Delhi - 110055

Ind-Swift Laboratories Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Ind-Swift Labs. 358.50 682.84 635.89 52.95 4.39
Abbott India 26,068.45 7,217.19 6,929.05 34.31 43.78
Astrazeneca Phar 5,922.60 2,304.07 2,275.58 87.29 27.86
Glaxosmi. Pharma 2,523.00 3,932.76 3,790.20 40.30 58.17
Novartis India 1,937.30 393.10 354.33 48.92 15.94
Cipla 1,333.70 20,102.60 18,979.95 35.05 13.88
Bliss GVS Pharma 655.95 773.53 729.81 60.96 12.51
Amrutanjan Healt 506.40 520.13 502.55 27.12 24.16
Fermenta Biotec. 486.65 474.15 450.25 22.72 18.77
Guj. Themis Bio. 370.70 168.25 165.82 99.12 18.05
Ambalal Sarabhai 38.15 19.52 3.94 70.65 6.77